Inside Innovation

The inspiration behind the Invent at Seattle Children’s Postdoctoral Scholars Program began at a workshop. Eric Nealy, who saw what the life sciences field could

David Younger, co-founder and CEO of Seattle-based biotech A-Alpha Bio is a Puget Sound Business Journal 40 under 40 honoree. Younger co-founded the company in

The inspiration behind the Invent at Seattle Children’s Postdoctoral Scholars Program began at a workshop. Eric Nealy, who saw what the life sciences field could

The Seattle-area company, Sonoma Biotherapeutics has partnered with Regeneron in a $75 million upfront deal with plans to co-develop therapies to treat Crohn’s disease and

Biotech giant Moderna is making its way to Seattle with a new office opening in South Lake Union on April 4. The company plans to

Washington remains a top life science cluster with exciting and innovative news from companies across the state. Whether it’s a record-breaking deal with Pfizer acquiring

As the global pharmaceutical market is expected to reach over $1.5 trillion by the end of 2023, life sciences is entering a new era of

The Fred Hutchinson Cancer Center revealed a $320 million clinic expansion in South Lake Union to fuel continued growth and work in cancer breakthroughs. The

After Pfizer’s $43 billion plan to buy Bothell, Wash.-based biotech giant, Seagen, Seattle-area biotech experts believe that Seagen’s technology and talent will be a great

In a $43 billion deal, Pfizer will acquire Bothell-based biotech Seagen, expected to be completed in late 2023 or early 2024. Pfizer intends to maintain

CBRE’s recent report for Q4 2022 shows promise for the future of Seattle’s life science industry. The region recorded its highest fourth-quarter capital funding on

Moderna wants to tap Seattle’s pool of talent, the Cambridge, Massachusetts-based company announced last week. It is opening an office on April 4 with plans